Dante Labs

Dante Labs

[Closed for Investment] Who Should Be Interested:
Have you always wanted to know your DNA makeup? Are you interested in finding out your genetic history when it comes to hereditary diseases, health conditions, and traits? If you said yes, then investing in Dante Labs might be for you. They offer some of the most complete -- and affordable -- DNA tests on the market and can provide you with significant and deep genetic insights.

The Company:
The co-founders of Dante Labs came together in shared indignation about a woman being denied genetic testing -- despite a family history of a hereditary disease. Their response was to create this company and help people learn about their DNA and genetic history. Dante Labs analyzes 100% of your DNA for just $695, making it not only the most complete DNA tests available in the market, but one of the most affordable, too. They offer a variety of products and different prices, and all of them can provide consumers with hundreds of insights about hereditary diseases, health conditions, and traits. So far, Dante Labs has earned over $250,000 of revenue from DNA tests since their April 2017 launch, and 70% of their sales are from organic traffic. They’re partnering with leaders in genetics, including Illumina and BGI, as well as several European doctors and universities, and they’re a member of both the WeWork Labs accelerator and Amazon Launchpad.

The Bottom Line:
Knowing your family history isn’t just fun -- it’s important for your health, too. Dante Labs is making that knowledge accessible and affordable, and when you combine their technology with the co-founders experience in global genetics and e-commerce, you can see that Dante Labs is on its way to a genetic path to success.

Expand

Investment Overview

Raised this Round: Raised: $583,123

Deal Terms

Total Commitments ($USD)

Platform
SeedInvest
Start Date
02/19/2018
Close Date
04/20/2018
Min. Goal
$250,000
Max. Goal
$1,000,000
Min. Investment

$500

Security Type

Debt

SEC Filing Type

RegCF / RegD 506(c)    Open SEC Filing

Company & Team

Company

Year Founded
2017
Industry
Healthcare & Pharmaceuticals
Tech Sector
Location
New York, New York
Company Website
Visit Website

Team

Financials

Financials are not currently available for this company. This may occur if the company is still Testing the Waters, is a Regulation D offering, or if the financials are still under review and being confirmed by our team. For Reg CF and Reg A+ raises, please check back later.

Upgrade to gain access

Pay Monthly
Annually (2 months free)

Edge

$12.50 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific Kingscrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Company Funding & Growth

Funding history

Close Date Platform Valuation Total Raised Security Type Status Reg Type
04/20/2018 SeedInvest - $583,123 Debt Funded RegCF / RegD 506(c)
Create a free account today to gain access to Kingscrowd analytics.
Founders: enhance your startup's credibility on Kingscrowd. Create an account to claim this raise page.
Add to portfolio
Dante Labs on SeedInvest
Platform: SeedInvest
Security Type: Debt

Follow company

Follow Dante Labs on SeedInvest

Buy Dante Labs's Deal Report

Warning: according to the close date for this deal, Dante Labs may no longer be accepting investments.

Dante Labs Deal Report

Get Kingscrowd's comprehensive report on Dante Labs including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Dante Labs is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Dante Labs deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge